Skip to main content
. 2022 Jan 20;13:411. doi: 10.1038/s41467-022-28068-3

Table 1.

Unweighted and weighted cohort characteristics (N = 883,416) of unvaccinated individuals, CoronaVac, or Comirnaty recipients.

Unvaccinated CoronaVac Comirnaty Unvaccinated CoronaVac Comirnaty
Unweighted Weighteda
n 547,796 182,442 153,178 536,072 124,524 96,322 Maximum weighted SMD
Age [mean (SD)] 62.11 (12.85) 61.58 (11.08) 56.81 (13.43) 61.08 (13.33) 61.08 (11.31) 61.08 (12.17) <0.001
Sex: male (%) 229,791 (41.9) 88,881 (48.7) 72,586 (47.4) 242587.9 (44.3) 80814.1 (44.3) 67831.5 (44.3) <0.001
Chronic conditions (%)
 Hypertension 367,799 (67.1) 125,314 (68.7) 93,319 (60.9) 363621.4 (66.4) 121104.0 (66.4) 101688.5 (66.4) <0.001
 Diabetes (type 2) 180,875 (33.0) 51,312 (28.1) 36,403 (23.8) 166524.0 (30.4) 55471.7 (30.4) 46570.1 (30.4) <0.001
 Severe constipation 45,405 (8.3) 16,424 (9.0) 13,804 (9.0) 46915.4 (8.6) 15619.6 (8.6) 13111.6 (8.6) <0.001
 Depression 34,333 (6.3) 10,745 (5.9) 13,310 (8.7) 36257.6 (6.6) 12056.4 (6.6) 10126.4 (6.6) <0.001
 Cancer 31,308 (5.7) 4671 (2.6) 4733 (3.1) 25244.0 (4.6) 8407.6 (4.6) 7050.6 (4.6) <0.001
 Hypothyroidism 27,752 (5.1) 9555 (5.2) 9508 (6.2) 29019.7 (5.3) 9673.0 (5.3) 8119.2 (5.3) <0.001
 Chronic pain 23,305 (4.3) 7577 (4.2) 7845 (5.1) 24013.3 (4.4) 8006.3 (4.4) 6699.9 (4.4) <0.001
 Asthma 18,172 (3.3) 5119 (2.8) 7061 (4.6) 18773.8 (3.4) 6277.3 (3.4) 5265.2 (3.4) <0.001
 Chronic pulmonary disease 12,090 (2.2) 2638 (1.4) 1663 (1.1) 10152.9 (1.9) 3373.7 (1.8) 2846.7 (1.9) <0.001
 Schizophrenia 10,915 (2.0) 1634 (0.9) 1637 (1.1) 8803.3 (1.6) 2930.7 (1.6) 2463.7 (1.6) <0.001
 Rheumatoid arthritis 7654 (1.4) 1582 (0.9) 1663 (1.1) 6783.9 (1.2) 2257.3 (1.2) 1883.2 (1.2) <0.001
 Peptic ulcer disease 6662 (1.2) 2224 (1.2) 1583 (1.0) 6502.3 (1.2) 2162.0 (1.2) 1810.1 (1.2) <0.001
 Alcohol misuse 4535 (0.8) 1356 (0.7) 1278 (0.8) 4441.6 (0.8) 1468.2 (0.8) 1242.3 (0.8) <0.001
 Cirrhosis 3294 (0.6) 544 (0.3) 433 (0.3) 2634.9 (0.5) 876.7 (0.5) 746.0 (0.5) <0.001
 Parkinson’s disease 3182 (0.6) 409 (0.2) 336 (0.2) 2419.1 (0.4) 811.4 (0.4) 685.1 (0.4) <0.001
 Dementia 3030 (0.6) 299 (0.2) 204 (0.1) 2184.8 (0.4) 734.9 (0.4) 607.3 (0.4) 0.001
 Psoriasis 2524 (0.5) 721 (0.4) 814 (0.5) 2513.0 (0.5) 836.6 (0.5) 705.5 (0.5) <0.001
 Irritable bowel syndrome 1710 (0.3) 621 (0.3) 823 (0.5) 1960.3 (0.4) 652.3 (0.4) 545.5 (0.4) <0.001
 Inflammatory bowel disease 1548 (0.3) 360 (0.2) 595 (0.4) 1584.6 (0.3) 514.3 (0.3) 427.3 (0.3) 0.002
 Peripheral vascular disease 93 (0.0) 9 (0.0) 9 (0.0) 91.5 (0.0) 8.7 (0.0) 13.9 (0.0) 0.012
Multimorbidity statusb (%) 0.012
 One condition 344,866 (63.0) 128,890 (70.6) 114,311 (74.6) 363464.1 (66.4) 121971.7 (66.9) 102332.2 (66.8)
 Two conditions 168,166 (30.7) 46,844 (25.7) 34,071 (22.2) 155986.2 (28.5) 51013.4 (28.0) 42906.3 (28.0)
 Three conditions 28,767 (5.3) 5893 (3.2) 4224 (2.8) 23974.7 (4.4) 7938.7 (4.4) 6712.3 (4.4)
 Four or more conditions 5997 (1.1) 815 (0.4) 572 (0.4) 4371.0 (0.8) 1518.2 (0.8) 1227.3 (0.8)
Adverse events of special interestb (%)
 Cardiovascular system 759 (0.1) 160 (0.1) 106 (0.1) 737.8 (0.1) 158.1 (0.1) 118.0 (0.1)
 Circulatory system 689 (0.1) 135 (0.1) 113 (0.1) 664.4 (0.1) 131.6 (0.1) 134.3 (0.1)
 Hepato-renal system 513 (0.1) 148 (0.1) 86 (0.1) 508.3 (0.1) 147.9 (0.1) 85.7 (0.1)
 Auto-immune diseases 229 (0.0) 40 (0.0) 55 (0.0) 233.5 (0.0) 41.3 (0.0) 50.6 (0.0)
 Respiratory system 154 (0.0) 18 (0.0) 10 (0.0) 140.9 (0.0) 17.9 (0.0) 12.9 (0.0)
 Other system 113 (0.0) 42 (0.0) 43 (0.0) 105.9 (0.0) 43.3 (0.0) 33.7 (0.0)
 Nerves and central nervous system 63 (0.0) 14 (0.0) 16 (0.0) 59.5 (0.0) 13.6 (0.0) 16.6 (0.0)
 Skin, bone, and joints system 2 (0.0) 1 (0.0) 4 (0.0) 1.7 (0.0) 1.1 (0.0) 2.9 (0.0)

SMD standardized mean difference.

a Weighting variables: age, sex, hypertension, diabetes mellitus (type 2), severe constipation, depression, cancer, hypothyroidism, chronic pain, asthma, alcohol misuse, chronic pulmonary disease, schizophrenia, rheumatoid arthritis, peptic ulcer disease, cirrhosis, psoriasis, Parkinson’s disease, dementia, irritable bowel syndrome, inflammatory bowel disease, and peripheral vascular disease.

b Not included for weighting.